Luxembourg vs New Zealand: Antiretroviral therapy coverage
Luxembourg
84.0%
in 2024
New Zealand
84.0%
in 2024
Luxembourg rank
41st
New Zealand rank
41st
Antiretroviral therapy coverage over time
- Luxembourg
- New Zealand
How they compare
Luxembourg currently reports 84.0% against 84.0% in New Zealand, a difference of 0.0%.
The two have swapped places 11 times across 25 shared years of data; in 2000 it was Luxembourg ahead.
Luxembourg ranks 41st and New Zealand ranks 41st of 143 countries.
Across the 3 decades both report, Luxembourg averaged higher in 1 and New Zealand in 1.
Head to head by decade
| Decade | Luxembourg | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.7% | 43.1% | 1.6% | Luxembourg |
| 2010s | 63.6% | 64.1% | 0.5% | New Zealand |
| 2020s | 79.2% | 79.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Luxembourg or New Zealand?
- Luxembourg, at 84.0% against 84.0% in New Zealand as of 2024.
- What is the difference in antiretroviral therapy coverage between Luxembourg and New Zealand?
- 0.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and New Zealand?
- 25 years are reported by both, from 2000 to 2024.
- How do Luxembourg and New Zealand rank globally for antiretroviral therapy coverage?
- Luxembourg ranks 41st and New Zealand ranks 41st of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.